What is nanostring technologies nstg? NanoString Technologies ( NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company’s technology enables a wide variety of basic research and translational medicine applications.Who is the ceo of nanostring? Brad Gray, a former Genzyme executive, was hired as president and CEO in 2010. As of June 2010, the company was not yet profitable. In an interview, Gray suggested that NanoString would begin to develop clinical diagnostics.What is nanonanostring technologies? NanoString Technologies, Inc. (NASDAQ: NSTG) is a publicly held biotech company that specializes in development of cancer diagnostics tools. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.What is it like to work at nanostring? “NanoString is a uniquely innovative place to work, as we get to do far more exciting and cutting-edge science than most companies our size. We experience the thrill of building technologies alongside the satisfaction that comes from participating in research advancing patient care for a broad range of disease areas.”
Contact and general information about NanoString Technologies company, headquarter location in United States. Email formats & phone numbers of NanoString Technologies 100-200 employees. Software Development